In vivo safety profile of a CSPG4-directed IgE antibody in an immunocompetent rat model (2019)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/19420862.2019.1685349
PubMed Identifier: 31769737
Publication URI: http://europepmc.org/abstract/MED/31769737
Type: Journal Article/Review
Parent Publication: mAbs
Issue: 1
ISSN: 1942-0862